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Rapid detection of functional gene 
polymorphisms of TLRs and IL-17 
using high resolution melting 
analysis
Johanna Teräsjärvi1, Antti Hakanen2, Matti Korppi3, Kirsi Nuolivirta4,  
Kirsi Gröndahl-Yli-Hannuksela1, Jussi Mertsola5, Ville Peltola5 & Qiushui He1,6
Genetic variations in toll-like receptors (TLRs) and IL-17A have been widely connected to different 
diseases. Associations between susceptibility and resistance to different infections and single 
nucleotide polymorphisms (SNPs) in TLR1 to TLR4 and IL17A have been found. In this study, we aimed 
to develop a rapid and high throughput method to detect functional SNPs of above mentioned proteins. 
The following most studied and clinically important SNPs: TLR1 (rs5743618), TLR2 (rs5743708), TLR3 
(rs3775291), TLR4 (rs4986790) and IL17 (rs2275913) were tested. High resolution melting analysis 
(HRMA) based on real-time PCR combined with melting analysis of a saturating double stranded-
DNA binding dye was developed and used. The obtained results were compared to the “standard” 
sequencing method. A total of 113 DNA samples with known genotypes were included. The HRMA 
method correctly identified all genotypes of these five SNPs. Co-efficient values of variation of intra- 
and inter-run precision repeatability ranged from 0.04 to 0.23%. The determined limit of qualification 
for testing samples was from 0.5 to 8.0 ng/μl. The identical genotyping result was obtained from the 
same sample with these concentrations. Compared to “standard” sequencing methods HRMA is cost-
effective, rapid and simple. All the five SNPs can be analyzed separately or in combination.
Toll-like receptors (TLR) are a critical part of innate immunity. So far, ten functional TLRs have been identified in 
humans. TLRs recognize a wide range of pathogen-associated molecular patterns (PAMPs) from microorganisms 
and danger-associated molecular patterns (DAMPs) released from damaged tissue1,2. In turn, interleukins (ILs) 
are a large group of immune modulating proteins that bind to their specific receptors and play an important role 
in the communication in the immune system3.
TLR2 and TLR1 are members of the TLR2 subfamily which comprises TLR1, TLR2, TLR6 and TLR10. TLR1 
is co-receptor of TLR2 and they occur as heterodimers on a cell surface. TLR1 and TLR2 are capable of detecting 
a wide range of ligands, especially from Gram-positive bacteria and mycobacteria. The main ligand of TLR2 is 
peptidoglycan and that of TLR1 is triacylated lipopeptide. TLR3 is located on the surface of endosome and it 
recognizes viral dsRNA, synthetic oligonucleotides and DAMPs. TLR4 is located on the cell surface or on the 
surface of endosome. It recognizes lipopolysaccharides (LPS) and PAMPs of Gram-negative bacteria4. Both TLR3 
and TLR4 are also innate antiviral immune response receptors. IL17 (IL17A) is a pro-inflammatory cytokine. It 
is produced by different types of cells, including CD4+ T cells and neutrophils. IL17 orchestrates for recruitment 
of neutrophils and stimulates production of the antimicrobial peptides3.
Genetic variations, especially single nucleotide point mutations (SNPs) can affect development of disease in 
individuals and responses to pathogens, drugs, vaccines and other agents. Recent studies have shown a num-
ber of SNPs in genes coding the TLR1, TLR2, TLR3, TLR 4 and IL17A. These SNPs have been associated with 
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susceptibility or resistance to different infections4,5. In this study, we took into account the most studied and 
clinically important SNPs of the TLRs and IL17, which are listed in Table 1.
One of the most studied SNPs in TLR2 gene is 2258G > A (rs5743708). This SNP causes amino acid substi-
tution from arginine (Arg) to glutamine (Gln) in the C-terminal end of the TLR2 at position of 753. Individuals 
who carry the minor allele A, may have increased risk for atopy6, sepsis7,8 and susceptibility to tuberculosis9,10. 
Haerynck and his colleagues have found a correlation between allele A and faster decline of forced expiratory 
volume 1 (FEV1) result of patients with cystic fibrosis11. Schröder et al. have shown that heterozygous polymor-
phism (Arg753Gln) can impair immune activation by Borrelia burgdorferi and may protect from late stage Lyme 
disease12. The SNP 1805G > T (rs5743618) in TLR1 gene leads to substitution of amino acid at the position 602 
from serine (Ser) to isoleucine (Ile) on the cytoplasmic side of the transmembrane domain of the receptor. It 
affects the cell surface trafficking in several cell types4. Allele G, which is a minor allele in all other populations, 
except Europeans, is associated with increased susceptibility to asthma and allergic rhinitis after hospitalization 
due to bronchiolitis in infancy13 and is also a risk factor of tuberculosis14–16. The SNP 1234C > T (rs3775291) in 
TLR3 gene causes an amino acid change from leucine (Leu) to phenylalanine (Phe) at the position 412 in the 
extracellular domain of this protein. The dominant allele C was found to be a risk factor for tick-borne encephali-
tis virus (TBEV)17–19 and bronchiolitis in early infancy20. TLR4 SNP 896A > G (rs4986790) causes an amino acid 
change from aspartic acid (Asp) to glycine (Gly) at the position of 299. It is located in the extracellular domain 
of this protein. In the previous studies we have shown an association between the minor allele G and increased 
risk of repeated colonization of Moraxella catarrhalis21. The allele G has also been connected to an increased risk 
of different disorders caused by bacteria and viruses, such as septic shock due to infection by Gram-negative 
bacteria22,23, increased mortality of children with invasive meningococcal disease24, chronic cavitary pulmonary 
aspergillosis25 and susceptibility to respiratory syncytial virus (RSV) infection26. The IL17A SNP − 197G > A 
(rs2275913) is located in the promoter of IL17A gene and has an effect on its transcriptional regulation. Children 
who carry genotype AA of IL17A have usually low serum level of IL17A. We have previously reported an asso-
ciation between the minor allele A and increased colonization of Streptococcus pneumoniae in young Finnish 
children27. Other studies have shown associations of the allele A with gastrointestinal diseases28 and childhood 
asthma29. The SNPs studied in TLRs and IL17A and potential effects on susceptibility and resistance to different 
diseases are summarized in Table 1.
Direct DNA sequencing is considered a “golden standard” for identification of the SNPs. However, the melting 
properties of DNA have enabled the development of many rapid and high throughput methods30, high resolution 
melting analysis (HRMA) being one of them. The method is based on analysis of released fluorescence from 
binding dye of the double stranded DNA (dsDNA) and is proven to be a simple, relatively rapid and low-cost 
tool for SNP scanning. PCR is the first step of HRMA followed by binding of a dye. The dye binds to dsDNA, 
when amplicons are denatured and then rapidly re-annealed. Melting analysis starts when dsDNA amplicons 
with saturated dye are gradually heated and release the fluorescence dye. The data can then be analyzed based 
on the melting temperature (Tm) and on the shape of the normalized melting curves. HRMA is ideal for clinical 
use because PCR amplification and melting curve analysis can be performed on the same plate and without any 
post-PCR processing. This saves time and decreases the risk of contamination.
HRMA method has been used for genotyping of Yersinia enterocolitica31, for screening of oncogene mutations32  
and for identifying of common variants in methylenetetrahydrofolate reductase (MTHFR) gene33. A meta analysis 
has shown that HRMA method is a highly sensitive, simple and low-cost test to detect human disease-associated 
mutations, especially for samples with mutations of low incidence34. Recently HRMA method has been applied 
for detection of TLR1 (rs5743618), TLR2 (rs5743708) and TLR4 (rs4986790) SNPs35–37.
In our previous studies, we have used PCR-based pyrosequencing, Sanger sequencing and Sequenom mas-
sARRAY iPlex Gold method for detecting the functional SNPs of TLRs21 and IL1727. These methods are generally 
time consuming and expensive, especially for a large number of samples. Increased knowledge of function and 
importance of TLRs and ILs have aroused the interest in clinicians to variations of functional SNPs. In this present 
study we aimed to develop a high throughput method based on HRMA for rapid detection of TLR1 (rs5743618), 
TLR2 (rs5743708), TLR3 (rs3775291), TLR4 (rs4986790) and IL17A (rs2275913). The knowledge of the genetic 
variations in these important molecules will increase our understanding of why some individuals have higher 
Target SNP id
Nucleotide 
change
Amino acid 
change
Allele Frequency  
(1000 Genome project)*
Allele Frequency 
of this study
Potential effect and reported 
associations
TLR1 rs5743618 1805G > T Ser > Ile A: 0.172 C: 0.828 A: 0.208 C: 0.792 Compromised signaling; Asthma, Allergic rhinitis and TB 
TLR2 rs5743708 2258G > A Arg > Gln G: 0.970 A: 0.030 G: 0.948 A: 0.052 Compromised signaling; Sepsis, TB, Atopy, Cystic Fibrosis decline
TLR3 rs3775291 1234C > T Leu > Phe C: 0.667 T: 0.333 C: 0.578 T: 0.422 Compromised signaling; Tick-borne encephalitis virus (TBE), Bronchiolitis 
TLR4 rs4986790 896A > G Asp > Gly A: 0.884 G: 0.116 A: 0.848 G: 0.155
Hyporesponsiveness; M.catarrhalis and 
H.influenzae colonization, Septic shock, 
Respiratory syncytial virus (RSV)
IL17A rs2275913 − 197G > A — G: 0.571 A: 0.429 G: 0.530 A: 0.470
Reduced production; S.pneumoniae 
colonization, Childhood asthma, 
Gastrointestinal diseases
Table 1.  Function of the studied SNPs and the allele frequencies reported in Finnish population (1000 
Genome project) and in this study. *Reference 42.
www.nature.com/scientificreports/
3Scientific RepoRts | 7:41522 | DOI: 10.1038/srep41522
likelihood of infections and different outcomes after the diseases. In the future this knowledge may help plan a 
more personalized care chain.
Normally, the validation and verification of a method follow ISO standards or Organization for Economic 
Cooperation and Development guidelines. For HRMA validation there are no such standards available. We used 
selected validation parameters, which are described in previous literature30,33.
Results
PCR and HRM parameters optimization. Three samples with known genotypes were used to determine 
the proper concentration of MgCl2 and annealing temperature (Ta °C) for each individual assay, shown in Table 2. 
In order for the method to be suitable for diagnostic use it would be necessary to analyze all the SNPs on one plate 
during the same run. Therefore, the second step on the optimization process was to find out the optimal annealing 
temperature (Ta) which works for all used primer sets. The optimal Ta varied between 60.2 °C and 57 °C in individ-
ual assays. Two test runs were made and the annealing temperature was set at 58 °C on the first run and at 59 °C 
on the second run. When comparing the annealing curves and melting profiles, the higher annealing temperature 
gives more representative results, thus 59 °C is used as the annealing temperature in the assay.
Validation. Based on the optimization runs, two samples with the best melting curve, were chosen to repre-
sent each variant and later these samples were used as the controls. Melting curves of different genotypes of TLR1, 
TLR2 and TLR3 used as controls are shown in Fig. 1 and those of TLR4 and IL17 are shown in Fig. 2. Sequences 
of the controls were confirmed by Sanger sequencing (data not shown).
Total of 77 samples were used to test the method accuracy of TLR1 (rs5743618), TLR2 (rs5743708) and TLR3 
(rs3775291). The results obtained by HRMA were compared to pyrosequencing results. Resemblance between 
HRMA and sequencing genotyping results was 100%. Total of 60 samples were used to test the method accu-
racy of TLR4 (rs4986790) and IL17 (rs2275913). The results obtained by HRMA were compared to those by 
pyrosequencing (TLR4) and Sequenom massARRAY iPlex Gold method (IL17). Identical genotyping results 
were obtained.
For analysis of melting curves, all tested samples were grouped together with regard to the controls, and 
melting profiles were identical for DNA samples with the same genotype. The coefficient of variation (CV) of 
intra- and inter-run precision-repeatability varied between 0.04 and 0.23%. In TLRs and IL17A genotypes there 
were no considerable differences in CV% of melting profiles.
The limit of quantification was tested for the five studied SNPs using a DNA template. Two fold serial dilutions 
of the sample were used, ranging from 0.5 to 8.0 ng/μ l. The identical genotyping result was obtained from the 
same sample with different concentrations for all five studied SNPs. Only a marginal change in melting curve pro-
files and melting temperatures was observed between different DNA concentrations of the same sample (Fig. 3).
Confirmation of TLR1 SNP. At the beginning of this study we noticed that HRMA melting curves and 
sequencing diagrams were atypical for the TLR1 (rs5743618).  HRMA clearly divided the six testing samples 
with known three genotypes (two for each wild type, heterozygote variant and homozygote variant) in three 
different groups (Fig. 5a–c). Although the sequencing diagram (Fig. 4a) showed that there was a nucleotide 
T-peak in each sample, even in those which were supposed to be the homozygous wild type G genotype. We 
thus performed a Genbank searching and found that TLR1 primer set used for HRMA was not specific only 
for TLR1 rs5743618 (1805G < T), but the primers were also capable of binding to TLR6 gene. The closer exam-
ination uncovered a ~300 bp area in TLR1, with 97% similarity to TLR6. The background peak T was actually 
derived from co-amplification of the TLR6 and TLR1 genes. In order to differentiate the three genotypes of TLR1 
rs5743618 we redesigned a set of primers only specific to TLR1. The background peak T in the TLR1 sequence 
disappeared after the pre-PCR step (Fig. 4b) and both normalized HRMA curves became typical (Fig. 5e,f). The 
three genotypes of TLR1 rs5743618 (1805G < T) were clearly distinguished by HRMA no matter whether the 
pre-PCR step was performed or not (Fig. 5).
Target SNP id Primers
Product size 
(bp)
Annealing temperature 
(⁰C)
MgCl2 concentration 
(mM)
TLR1 rs5743618 F:5′ -CTGGCACACCATCCTGAGAT-3′  R:5′ -GTTGGCTGTGACTGTGACCT-3′ 70 57 2.5
TLR2 rs5743708 F:5′ -TCTCAATTCTTCTGGAGCCCAT-3′  R:5′ -GGCCACTCCAGGTAGGTCT-3′ 96 57 2.5
TLR3 rs3775291 F:5′ -ACTTGCTCATTCTCCCTTACACAT-3′  R:5′ -GCCCAATTTCATTAAGGCCCA-3′ 125 60 3
TLR4 rs4986790 F:5′ -ACCATTGAAGAATTCCGATTAGCA-3′ R:5′ -CCAGGGAAAATGAAGAAACATTTG-3′ 95 59 2.5
IL17A rs2275913 F:5′ -TCTGCCCTTCCCATTTTCCTTC-3′  R:5′ -GGTTAAAATTTCCGCCCCCAATT-3′ 70 59 3
Table 2.  Primers and parameters used in the High Resolution Melting Analyze in each individual assay*. 
*Annealing temperature 59 °C was used when analyzing all the five SNPs in same run.
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Discussion
The purpose of the study was to develop a rapid, less expensive and high throughput genotyping method for 
functional polymorphism of important innate immune genes such as TLRs and IL-17. A set of samples were 
selected from two of our earlier studies: bronchiolitis and STEPS studies conducted in Finland in which func-
tional SNPs of TLRs and IL-17 were analyzed to find out their associations with development of subsequent infec-
tions and post-bronchiolitis outcomes13,20,21,27,38. The genotyping method was based on real-time PCR combined 
with HRMA. The results were compared to the PCR-based sequencing methods such as pyrosequencing and 
Sanger sequencing. All studied genotypes of these four TLRs and IL-17A were correctly identified with HRMA. 
Compared to the “traditional” sequencing methods HRMA is cost-effective, rapid and simple. All the five SNPs 
can be analyzed separately or together which make it well-adapted analysis tool for diagnostic use.
In general, post-PCR melting analyses are used to separate homozygote and heterozygote variants. Separation 
between homozygote wild type and homozygote variants is more difficult, because they differ only in between 
melting temperatures (Tm) but the shapes of normalized and shifted melting curves are generally similar (Fig. 1h). 
In our case, the difference between a homozygote wild type and a homozygote variant is > 0,5 °C. These types 
of SNPs are relatively easy to be differentiated, but when analyzing all the SNPs on the same plate at the same 
time, PCR and melting conditions require certain compromises. In this case, the annealing conditions of PCR 
are not fully optimized for all the SNPs. In our study, annealing temperature was optimal for IL-17 and TLR4 
(Table 2). Because of this, the shapes of the melting curves for the TLR1–3 were not as sharp and representative 
as they were when tested separately. However, simultaneous amplifications of the five PCRs were proven to be 
specific and we were able to distinguish genotypes of all these five SNPs. Moreover, both intra- and inter-run 
precision-repeatability CV were very low (< 0,2%), showing that HRMA is a reliable method for the SNP analysis 
of TLR1-4 and IL17A.
TLR1, TLR2, TLR6 and TLR10 comprise the TLR2 subfamily. These TLRs have similarities in their structure 
and sequence. The sequence similarities may become a problem when using HRMA to determine the TLR SNPs 
of this subfamily. We met this kind of problem with TLR1 SNP rs5743618. The SNP is located in the middle of 
~300 bp area with 97% similarity to TLR6 gene. We used the pre-PCR step to confirm the identity of each TLR1 
variant. In the TLR6 gene there is also a SNP (rs62622399) in the same location as TLR1 SNP rs5743618. The 
SNP in TLR6 gene has been found only in one small Banthu population in Africa. Since TLR6 SNP rs62622399 is 
extremely rare (only reported in two cases) and the pre-PCR step is quite laborious for the routine diagnostic test, 
TLR1 SNP rs5743618 can be analyzed without the pre-PCR step, as clearly shown in Fig. 5.
Figure 1. Analysis of TLR1 SNP 1805G > T (rs5743618), TLR2 SNP 2258 G > A (rs5743708) and TLR3 
SNP 1234C > T (rs3775291). The upper three pictures represent PCR amplification of TLR1 (a), TLR2 (d) and 
TLR3 (g). Normalized melting profiles of the SNPs are shown in middle three pictures (b,e and h). In the picture 
h can perceive how both homozygote genotypes (TLR3 C/C and T/T) forms similar normalized and shifted 
melting curve and heterozygous melting curve (TLR3 C/T) settles between the homozygote curves. The last 
pictures (c,f and i) represent normalized and temp-shifted difference plot of the TLR1, TLR2 and TLR3 SNPs. 
In figure c TLR1 SNP (rs5743618) major genotype in Finnish population, was chosen to be as a baseline and in 
figures f and i wild type genotype was chosen to be as a baseline.
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Based on the previous studies39–41 it is known that high-resolution DNA melting analysis has some limita-
tions but in this study we have taken account these limitations and shown that HRMA is a reliable and accurate 
method for the SNP analysis of TLR 1-4 and IL17A. The best results are obtained when the control DNAs are of 
high-quality and the concentrations of these control DNAs and studied samples are closed to each other.
It is known that quantitative PCR is prone to have variation in the yield of amplified products, when different 
concentrations of target DNAs are used. In this present study, two-fold serial dilutions of a DNA sample ranging 
from 0.5 to 8.0 ng/μ l were used to test the effect. For all five studied SNPs, the identical genotyping result was 
obtained from the same DNA sample with different concentrations. Only a marginal change in melting curve pro-
files and melting temperatures was observed between different DNA concentrations of the same sample (Fig. 3). 
However, it should be kept in mind that the difference in DNA concentrations tested was only less than 16 folds.
TLRs and IL-17 are key molecules in innate and adaptive immunity. Genetic variations in TLRs and ILs have 
been widely connected to different diseases like cancer, autoimmunity disorders and infections. Furthermore, 
many studies have shown the associations between infections and SNPs in TLR2, TLR3, TLR4 and IL17A. These 
SNPs have been associated with susceptibility or resistance to different infections3–5. The methods developed 
in this study could be used for screening of patients with different disease conditions and the information will 
increase our understanding about the connections between different diseases and the SNPs and could provide a 
tool for clinicians to design more effective precision medicine.
Materials and Methods
Samples and DNA extraction. Total of 113 anonymously selected samples from two of our earlier studies13,20,21,27 
were used in this study. The first 53 DNA samples were isolated from the whole blood samples which were col-
lected from full-term infants hospitalized for bronchiolitis at < 6 months of age during the period December 1, 
2001 through May 31, 2002 and during the period from October 28, 2002 through May 31, 200413. These samples 
were stored at − 70 °C until DNA extraction. Rest of 113 samples were randomly selected DNA samples from 
a Finnish birth cohort study, called “Steps to the healthy development and well-being of children” (the STEPS 
study)38. The blood samples of the STEPS Study were taken between August 2008 and June 2010, when healthy 
infants visited the study clinic at the age of 2.6 months. These samples were immediately transported to the lab-
oratory, where the DNA extraction was performed. The DNA samples are stored at − 20 °C. The protocols of the 
Figure 2. Analysis of TLR4 SNP 896A > G (rs4986790) and IL17 SNP − 197G > A (rs2275913). The first 
pictures represent annealing step of TLR4 (a), and IL17 (d) PCR. The normalized melting profiles of the SNPs 
are shown in the two latter pictures (b and e). The last pictures (c and f) represent normalized and temp-shifted 
difference plot of the TLR4 and IL17 SNPs. Wild type genotype was chosen to be as a baseline.
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two studies were approved by the Ethics Committees of Tampere University Hospital District, Tampere and of 
the Hospital District of Southwest Finland, Turku, Finland. The parents of participating children provided their 
written, informed consent. The personal data of the study subjects were not given to the laboratory performing 
the genetic studies. The methods were carried out in accordance with the relevant guidelines, including any rel-
evant details.
In both cases, 200 μ l of the whole blood was used for DNA isolation. Extraction was done with QIAGEN 
QIAamp DNA Blood Mini Kit 250 (Qiagen, Hilden, Germany) according to the manufacturer’s protocol. DNA 
quality and concentration were measured by a spectrophotometer (NanoDrop ND-1000, Thermo Scientific, 
Waltham, Massachusetts, USA). The above mentioned five SNPs of TLR1, TLR2, TLR3 and IL17A were detected 
and the results have been previously published13,20,21,27,38.
Primer design. To maximize the difference between melting peaks (Tm) in variant genotypes, primers were 
designed to define a small fragment (< 150 bp) surrounding the SNP in interest. The manufacturer’s recommen-
dations for CG (%) content and primer melting temperatures were taken into account. Primers (Table 2) were 
designed with Primer-Blast design tool (http://www.ncbi.nlm.nih.gov/tools/primer-blast/).
TLR1 HRMA primers were set specific for SNP rs5743618 (1805G < T), which is located in the middle of ~300 
bp area with 97% similarity to TLR6. In order to separate the two TLRs, a Pre-PCR was used to confirm specific 
annealing and melting in HRMA. The sequences of the two primers used in the TLR1 pre-PCR were forward: 
5′ -GAAAGGAGACTGTTCTTGG-3′ and reverse: 5′-CTTTTGAGCTTGTGATAACTGCTAG -3′ .
All primers were ordered from Sigma-Aldrich Company (Saint Louis, Missouri, USA). The Primers used in 
HRMA were with HPCL quality.
Optimization of PCR and HRM parameters. All HRM analyses were performed by LightCycler480 
version 5.1 (Roche, Basal, Switzerland). Roche’s original melting master kit (LightCysler 480 High Resolution 
Melting Master) and 96-well plates (LightCycler 480 Multiwell 96, White) were used. Three samples with known 
genotypes were used to determine the proper concentration of MgCl2 and annealing temperature (Ta°C) for each 
individual assay (Table 2). Serial dilutions from 1 to 3.5mM of MgCl2 were tested. Determining Ta°C was carried 
out by a gradient PCR. In each run reaction volume was 20 μ l consisting of 3 μ l genomic DNA (8.0 ng/μ l) and 17 μ l 
of master mix including 10 μ l melting master dye with the additional concentration of MgCl2 (serial dilution) and 
Figure 3. Effect of the template DNA concentration on the annealing curves and melting profiles of the 
amplicons. 
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0.2 μ M of forward and reverse primers. The gradient PCR reaction program started with an initial denaturation 
of 10 min at 95 °C followed by 45 cycles amplification of 10s at 95 °C and annealing temperature gradient from 
57 °C to 62 °C and 15 s at 72 °C. After the PCR step, HRM melting cycle conditions were as outlined by Roche: 
first heated to 95 °C and held for 1 min, cooled to pre-hold temperature (40 °C) followed by melting interval for 
collecting fluorescence from 60 °C to 95° at ramp rate of 0.2 °C per second.
For TLR1 optimization both pure DNA and the PCR product from pre-PCR were used. The pre-PCR step was 
performed with Applied Biosystems Thermal Cycler (Thermo Scientific, Waltham, Massachusetts, USA), using 
Figure 4. TLR1 SNP 1805 G > T (rs574318) sequence before and after the pre-PCR. In the upper-part of the 
picture (a) is clearly to seen how the nucleotide T from TLR6 overlaps with TLR1 1805G > T (arrow). In the 
lower part of the figure (b) is shown the TLR1 SNP sequence after the pre-PCR step. After the pre-PCR step the 
HRMA primer set amplified only to TLR1 and the T-peak from the TLR6 SNP is not perceived in the sequence 
(arrows in lower part of figure).
Figure 5. Melting Peaks (a and d), Normalized and Shifted melting Curves (b and e) and Normalized and 
Temp-Shifted Difference Plots (c and f ) before and after the pre-PCR step. In both cases, before and after the 
pre-PCR step HRMA is capable to recognize all three genotypes. The curves before pre-PCR step are atypical 
(a,b and c), homozygote genotype GG exist like heterozygote variant. In lower part of the figure (d,e and f) 
curves are typical for each genotype.
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the following parameters; denaturation 10 min at 94 °C, 40 cycles at 94 °C, annealing at 55 °C for 40s and 72 °C for 
60s, followed by one cycle at 72 °C for 5 min.
The second step in the optimization process was to find out the optimal conditions where all the SNPs can be 
run on the same plate at the same time. Optimal MgCl2 concentrations are shown in Table 2. Optimal Ta varied 
between 57 °C and 60.2 °C. Two test runs were made. PCR and HRM conditions were the same as described pre-
viously, except the annealing temperature, which was on the first run 58 °C and on the second run 59 °C.
Agarose gel (1.5%) electrophoresis was used to confirm specific PCR amplifications.
Validation of HRM parameters. A total of 77 DNA samples were analyzed for TLR1–3 and 60 samples 
for TLR4 and IL17A SNPs (Table 2) by HRMA. Based on HRMA melting profiles of the SNPs two samples were 
selected to represent of each genotype. The samples were sent to the Finnish Institute for Molecular Medicine, 
Helsinki, Finland for sequencing to confirm the identity of the sequence. These samples were later used as the 
controls in each run.
Before the High Resolution Melting analysis, all samples were genotyped with an additional method, either 
pyrosequencing21, or Sequenom massARRAY iPlex Gold platform (IL17A)27. Resemblance between melting anal-
ysis and sequencing was determined and presented in % concordance.
Intra-assay precision reflects variability among replicate determinations within the same assay run. In turn, 
inter-run precision is the comparison of the results between the series run on different days. The same control 
samples were used in both assays. For intra-run assay the samples were prepared in five replicates at one con-
centration level in one trial run and for the inter-run assay the same DNA samples were analyzed in one trial 
performed on three different days using freshly prepared reagents. Intra- and inter-run precision-repeatability 
was presented as coefficient of variation (%).
Limit of Quantification was detected using a DNA template dilution ranging from 0.5 to 8.0 ng/μ l.
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